Status:
COMPLETED
Patient-reported Outcomes in the Treatment of Schizophrenia
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Schizophrenia
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Patient-reported health economic outcomes for patients enrolled in S1543003 and S1543004 protocols
Eligibility Criteria
Inclusion
- Participate in S1543003 and S1543004 in the U.S. sites
Exclusion
- Participate in S1543003 and S1543004 other than U.S. sites
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00230828
Start Date
May 1 2005
Last Update
September 12 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.